Farallon Capital Management 13F-HR Quarterly holdings report by institutional manager

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL

OMB Number:		3235-0006
Expires:	Oct 31, 2018
Estimated average burden
hours per response:		23.8

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5			COLUMN 6	COLUMN 7	COLUMN 8
			VALUE	SHRS OR	SH/	PUT/	INVESTMENT	OTHER	VOTING AUTHORITY
NAME OF ISSUER	TITLE OF CLASS	CUSIP	(x$1000)	PRN AMT	PRN	CALL	DISCRETION	MANAGER	SOLE	SHARED	NONE
ACCELERON PHARMA INC	COM	00434H108	313,725	2,500,000	SH		OTR		2,500,000	0	0
ACHILLES THERAPEUTICS PLC	SPONSORED ADS	00449L102	9,756	996,540	SH		OTR		996,540	0	0
AGILE GROWTH CORP	CLASS A ORD	G01202103	11,604	1,200,000	SH		OTR		1,200,000	0	0
AGILE GROWTH CORP	*W EXP 03/09/202	G01202111	380	399,999	SH		OTR		399,999	0	0
AGIOS PHARMACEUTICALS INC	COM	00847X104	63,928	1,160,000	SH		OTR		1,160,000	0	0
ALBIREO PHARMA INC	COM	01345P106	8,795	250,000	SH		OTR		250,000	0	0
ALEXION PHARMACEUTICALS INC	COM	015351109	1,415,945	7,707,500	SH		OTR		7,707,500	0	0
ALIBABA GROUP HLDG LTD	SPONSORED ADS	01609W102	153,394	676,400	SH		OTR		676,400	0	0
ALNYLAM PHARMACEUTICALS INC	COM	02043Q107	161,044	950,000	SH		OTR		950,000	0	0
ALPHA CAPITAL ACQUISITION CO	CL A ORD SHS	G0316P130	773	79,598	SH		OTR		79,598	0	0
ALPHA CAPITAL ACQUISITION CO	*W EXP 02/16/202	G0316P122	33	39,799	SH		OTR		39,799	0	0
ALPHABET INC	CAP STK CL C	02079K107	533,638	212,917	SH		OTR		212,917	0	0
AMYRIS INC	COM NEW	03236M200	214,611	13,110,000	SH		OTR		13,110,000	0	0
ANNEXON INC	COM	03589W102	30,571	1,358,107	SH		OTR		1,358,107	0	0
ANTHEM INC	COM	036752103	248,170	650,000	SH		OTR		650,000	0	0
AON PLC	SHS CL A	G0403H108	630,951	2,642,614	SH		OTR		2,642,614	0	0
APELLIS PHARMACEUTICALS INC	COM	03753U106	97,960	1,550,000	SH		OTR		1,550,000	0	0
APELLIS PHARMACEUTICALS INC	NOTE 3.500% 9/1	03753UAB2	7,995	4,250,000	PRN		OTR		4,250,000	0	0
APOLLO STRATEGIC GRWT CPTL I	SHS CL A	G0412A102	7,305	750,000	SH		OTR		750,000	0	0
APOLLO STRATEGIC GRWT CPTL I	*W EXP 02/12/202	G0412A128	185	150,000	SH		OTR		150,000	0	0
ARAMARK	COM	03852U106	454,858	12,210,950	SH		OTR		12,210,950	0	0
ARCLIGHT CLEAN TRANSITION II	CLASS A ORD SHS	G0R21B104	7,373	750,000	SH		OTR		750,000	0	0
ARCLIGHT CLEAN TRANSITION II	*W EXP 03/16/202	G0R21B112	261	150,000	SH		OTR		150,000	0	0
ARCTOS NORTHSTAR ACQUIS CORP	SHS CL A	G0477L100	1,946	200,000	SH		OTR		200,000	0	0
ARCTOS NORTHSTAR ACQUIS CORP	*W EXP 99/99/999	G0477L126	50	50,000	SH		OTR		50,000	0	0
ARENA PHARMACEUTICALS INC	COM NEW	040047607	57,970	850,000	SH		OTR		850,000	0	0
ARES ACQUISITION CORPORATION	*W EXP 99/99/999	G33032122	250	200,000	SH		OTR		200,000	0	0
ARES ACQUISITION CORPORATION	COM CL A	G33032106	9,750	1,000,000	SH		OTR		1,000,000	0	0
ARROWHEAD PHARMACEUTICALS IN	COM	04280A100	30,229	365,000	SH		OTR		365,000	0	0
ARYA SCIENCES ACQU CORP IV	CL A	G31659108	8,576	800,000	SH		OTR		800,000	0	0
ASCENDIS PHARMA A/S	SPONSORED ADR	04351P101	49,331	375,000	SH		OTR		375,000	0	0
ATENTO S A	SHS	L0427L204	57,186	2,230,357	SH		OTR		2,230,357	0	0
AUSTERLITZ ACQUISITION CORP	SHS CL A	G0633D109	20,928	2,109,700	SH		OTR		2,109,700	0	0
AUSTERLITZ ACQUISITION CORP	*W EXP 02/19/202	G0633D125	216	125,000	SH		OTR		125,000	0	0
AUSTERLITZ ACQUISITION CORP	COM CL A	G0633U101	14,595	1,500,000	SH		OTR		1,500,000	0	0
AUSTERLITZ ACQUISITION CORP	*W EXP 02/19/202	G0633U127	469	375,000	SH		OTR		375,000	0	0
AVANTOR INC	COM	05352A100	46,341	1,305,000	SH		OTR		1,305,000	0	0
AVITA MEDICAL INC	COM	05380C102	16,416	800,000	SH		OTR		800,000	0	0
AVROBIO INC	COM	05455M100	6,579	740,000	SH		OTR		740,000	0	0
BCTG ACQUISITION CORP	COM	05492W103	3,411	300,000	SH		OTR		300,000	0	0
BEAM THERAPEUTICS INC	COM	07373V105	193,065	1,500,000	SH		OTR		1,500,000	0	0
BHP GROUP PLC	SPONSORED ADR	05545E209	370,078	6,200,000	SH		OTR	1	6,200,000	0	0
BIG SKY GROWTH PARTNERS INC	CLASS A COM	08954L102	14,981	1,550,000	SH		OTR		1,550,000	0	0
BIG SKY GROWTH PARTNERS INC	*W EXP 04/01/202	08954L110	461	387,500	SH		OTR		387,500	0	0
BIOATLA INC	COM	09077B104	38,233	902,141	SH		OTR		902,141	0	0
BIOGEN INC	COM	09062X103	37,743	109,000	SH		OTR		109,000	0	0
BLACKSTONE GROUP INC	COM	09260D107	283,817	2,921,736	SH		OTR		2,921,736	0	0
BLUEPRINT MEDICINES CORP	COM	09627Y109	98,955	1,125,000	SH		OTR		1,125,000	0	0
BOSTON SCIENTIFIC CORP	COM	101137107	543,763	12,716,619	SH		OTR		12,716,619	0	0
BROADCOM INC	COM	11135F101	350,191	734,400	SH		OTR		734,400	0	0
BROADMARK RLTY CAP INC	COM	11135B100	62,269	5,880,000	SH		OTR		5,880,000	0	0
BROADMARK RLTY CAP INC	*W EXP 11/15/202	11135B118	1,291	7,174,613	SH		OTR		7,174,613	0	0
CARA THERAPEUTICS INC	COM	140755109	28,540	2,000,000	SH		OTR		2,000,000	0	0
CASCADE ACQUISITION CORP	COM CL A	147151104	9,781	990,000	SH		OTR		990,000	0	0
CASCADE ACQUISITION CORP	*W EXP 11/30/202	147151112	470	495,000	SH		OTR		495,000	0	0
CATALYST PARTNRS ACQUISITN C	UNIT 99/99/9999	G19550113	7,569	753,900	SH		OTR		753,900	0	0
CENTENE CORP DEL	COM	15135B101	346,418	4,750,000	SH		OTR		4,750,000	0	0
CEREVEL THERAPEUTICS HLDNG I	*W EXP 06/09/202	15678U102	1,913	134,175	SH		OTR		134,175	0	0
CF ACQUISITION CORP VI	COM CL A	12521J103	974	100,000	SH		OTR		100,000	0	0
CF ACQUISITION CORP VI	*W EXP 02/18/202	12521J111	25	25,000	SH		OTR		25,000	0	0
CHARTER COMMUNICATIONS INC N	CL A	16119P108	307,266	425,901	SH		OTR		425,901	0	0
CHURCHILL CAPITAL CORP VI	COM CL A	17143W101	3,944	400,000	SH		OTR		400,000	0	0
CHURCHILL CAPITAL CORP VI	*W EXP 02/17/202	17143W119	112	80,000	SH		OTR		80,000	0	0
CHURCHILL CAPITAL CORP VII	COM CL A	17144M102	9,730	1,000,000	SH		OTR		1,000,000	0	0
CHURCHILL CAPITAL CORP VII	*W EXP 02/29/202	17144M110	278	200,000	SH		OTR		200,000	0	0
CLEVER LEAVES HOLDINGS INC	COM	186760104	24,567	2,543,767	SH		OTR		2,543,767	0	0
CLOVIS ONCOLOGY INC	NOTE 1.250% 5/0	189464AC4	38,401	51,910,000	PRN		OTR		51,910,000	0	0
COGENT BIOSCIENCES INC	COM	19240Q201	4,866	600,000	SH		OTR		600,000	0	0
COLONNADE ACQUISITION CORP I	SHS CL A	G2284B101	4,883	500,000	SH		OTR		500,000	0	0
COLONNADE ACQUISITION CORP I	*W EXP 99/99/999	G2284B119	107	100,000	SH		OTR		100,000	0	0
CORAZON CAPITAL V838 MONOCER	CLASS A ORD SHS	G24237102	9,700	1,000,000	SH		OTR		1,000,000	0	0
CORAZON CAPITAL V838 MONOCER	*W EXP 03/24/202	G24237128	340	333,334	SH		OTR		333,334	0	0
COVANTA HLDG CORP	COM	22282E102	2,025	115,000	SH		OTR		115,000	0	0
CYTOKINETICS INC	COM NEW	23282W605	56,916	2,876,000	SH		OTR		2,876,000	0	0
DARIOHEALTH CORP	COM NEW	23725P209	11,534	540,000	SH		OTR		540,000	0	0
DECARBONIZATION PLUS ACQU II	CLASS A COM	24279D105	20,740	2,000,000	SH		OTR		2,000,000	0	0
DECARBONIZATION PLUS ACQU II	*W EXP 03/19/202	24279D113	1,693	666,666	SH		OTR		666,666	0	0
DISRUPTIVE ACQUISITION CORP	CLASS A ORD SHS	G2770Y102	13,580	1,400,000	SH		OTR		1,400,000	0	0
DISRUPTIVE ACQUISITION CORP	*W EXP 03/06/202	G2770Y128	429	466,667	SH		OTR		466,667	0	0
DRAGONEER GROWTH OPT CORP II	CL A SHS	G28315102	2,500	250,000	SH		OTR		250,000	0	0
ENANTA PHARMACEUTICALS INC	COM	29251M106	87,800	1,995,000	SH		OTR		1,995,000	0	0
EQUIFAX INC	COM	294429105	120,566	503,384	SH		OTR		503,384	0	0
EXACT SCIENCES CORP	COM	30063P105	31,078	250,000	SH		OTR		250,000	0	0
EXELIXIS INC	COM	30161Q104	200,420	11,000,000	SH		OTR		11,000,000	0	0
FACEBOOK INC	CL A	30303M102	426,482	1,226,545	SH		OTR		1,226,545	0	0
FATE THERAPEUTICS INC	COM	31189P102	165,335	1,905,000	SH		OTR		1,905,000	0	0
FIBROGEN INC	COM	31572Q808	38,319	1,438,927	SH		OTR		1,438,927	0	0
FIDELITY NATL INFORMATION SV	COM	31620M106	439,228	3,100,358	SH		OTR		3,100,358	0	0
FIFTH WALL ACQUISITION CORP	COM CL A	316790104	4,924	400,000	SH		OTR		400,000	0	0
FIFTH WALL ACQUISITN CORP III	CLASS A ORD SHS	G34142102	9,950	1,000,000	SH		OTR		1,000,000	0	0
FINCH THERAPEUTICS GROUP INC	COM	31773D101	2,608	185,344	SH		OTR		185,344	0	0
FINSERV ACQUISITION CORP II	COM CL A	31809Y103	5,820	600,000	SH		OTR		600,000	0	0
FINSERV ACQUISITION CORP II	*W EXP 02/17/202	31809Y111	180	150,000	SH		OTR		150,000	0	0
FIRST RESERVE SUSTAINABLE GW	CLASS A COM	336169107	3,876	400,000	SH		OTR		400,000	0	0
FIRST RESERVE SUSTAINABLE GW	*W EXP 03/05/202	336169115	120	100,000	SH		OTR		100,000	0	0
FOREST ROAD ACQUISITION COR	CL A	34619V103	12,250	1,250,000	SH		OTR		1,250,000	0	0
FOREST ROAD ACQUISITION COR	*W EXP 01/15/202	34619V111	349	250,000	SH		OTR		250,000	0	0
FORTRESS VALUE ACQUISI CORP	COM CL A	34964K108	17,168	1,750,000	SH		OTR		1,750,000	0	0
FORTRESS VALUE ACQUISI CORP	*W EXP 03/18/202	34964K116	280	218,748	SH		OTR		218,748	0	0
FORUM MERGER IV CORP	CLASS A COM	349875104	9,775	1,000,000	SH		OTR		1,000,000	0	0
FORUM MERGER IV CORP	*W EXP 03/15/202	349875112	323	250,000	SH		OTR		250,000	0	0
FS DEVELOPMENT CORP II	COM CL A	30318F100	10,000	1,000,000	SH		OTR		1,000,000	0	0
FTAC HERA ACQUISITION CORP	CLASS A ORD SHS	G3728Y103	4,875	500,000	SH		OTR		500,000	0	0
FTAC HERA ACQUISITION CORP	*W EXP 02/28/202	G3728Y111	165	125,000	SH		OTR		125,000	0	0
FULL TRUCK ALLIANCE CO LTD	SPONSORED ADS	35969L108	15,504	760,749	SH		OTR		760,749	0	0
G SQUARED ASCEND I INC	*W EXP 02/01/202	G4204R117	121	100,000	SH		OTR		100,000	0	0
G SQUARED ASCEND I INC	SHS CL A	G4204R109	4,935	500,000	SH		OTR		500,000	0	0
GENERATION BIO CO	COM	37148K100	94,150	3,500,000	SH		OTR		3,500,000	0	0
GOL LINHAS AEREAS INTELIGENT	SPON ADR PFD NEW	38045R206	791	85,838	SH		OTR		85,838	0	0
GORES HLDGS VIII INC	CL A	382863108	3,968	400,000	SH		OTR		400,000	0	0
GORES HLDGS VIII INC	*W EXP 03/01/202	382863116	63	50,000	SH		OTR		50,000	0	0
GORES HOLDINGS VII INC	COM CL A	38286T101	7,425	750,000	SH		OTR		750,000	0	0
GORES HOLDINGS VII INC	*W EXP 02/25/202	38286T119	128	93,750	SH		OTR		93,750	0	0
GORES METROPOULOS II INC	CL A	382873107	10,879	1,100,000	SH		OTR		1,100,000	0	0
GORES METROPOULOS II INC	*W EXP 01/31/202	382873115	210	150,000	SH		OTR		150,000	0	0
GORES TECHNOLOGY PARTNERS II	CLASS A COM	38287L107	5,946	600,000	SH		OTR		600,000	0	0
GORES TECHNOLOGY PARTNERS II	*W EXP 03/16/202	38287L115	215	120,000	SH		OTR		120,000	0	0
GORES TECHNOLOGY PARTNERS IN	CLASS A COM	382870103	2,513	250,000	SH		OTR		250,000	0	0
GORES TECHNOLOGY PARTNERS IN	*W EXP 03/16/202	382870111	67	50,000	SH		OTR		50,000	0	0
GOSSAMER BIO INC	COM	38341P102	1,643	202,326	SH		OTR		202,326	0	0
GRIFOLS S A	SP ADR REP B NVT	398438408	2,997	172,738	SH		OTR	1	172,738	0	0
GULFPORT ENERGY CORP	COMMON SHARES	402635502	45,125	697,444	SH		OTR		697,444	0	0
HARTFORD FINL SVCS GROUP INC	COM	416515104	9,296	150,000	SH		OTR		150,000	0	0
HILTON WORLDWIDE HLDGS INC	COM	43300A203	277,435	2,300,077	SH		OTR		2,300,077	0	0
HORIZON THERAPEUTICS PUB L	SHS	G46188101	46,820	500,000	SH		OTR		500,000	0	0
HOWMET AEROSPACE INC	COM	443201108	162,094	4,702,479	SH		OTR		4,702,479	0	0
HUDSON EXECUTIVE INVES III	COM CL A	44376L107	2,439	250,000	SH		OTR		250,000	0	0
HUDSON EXECUTIVE INVES III	*W EXP 02/22/202	44376L115	64	50,000	SH		OTR		50,000	0	0
HUMANCO ACQUISITION CORP	COM CL A	44487N109	4,962	508,900	SH		OTR		508,900	0	0
HUMANCO ACQUISITION CORP	*W EXP 99/99/999	44487N117	240	200,000	SH		OTR		200,000	0	0
IKENA ONCOLOGY INC	COM	45175G108	15,688	1,117,349	SH		OTR		1,117,349	0	0
IMMUNOGEN INC	COM	45253H101	4,943	750,000	SH		OTR		750,000	0	0
INHIBRX INC	COM	45720L107	15,668	569,328	SH		OTR		569,328	0	0
INSMED INC	NOTE 1.750% 1/1	457669AA7	52,504	50,000,000	PRN		OTR		50,000,000	0	0
INTERPRIVATE II ACQUISITION	CL A COM	46064Q108	3,880	400,000	SH		OTR		400,000	0	0
INTERPRIVATE II ACQUISITION	*W EXP 09/03/202	46064Q116	96	80,000	SH		OTR		80,000	0	0
INTERPRIVATE III FINANCIAL P	COM CL A	46064R106	3,880	400,000	SH		OTR		400,000	0	0
INTERPRIVATE III FINANCIAL P	*W EXP 99/99/999	46064R114	92	80,000	SH		OTR		80,000	0	0
INTERPRIVATE IV INFRATECH PR	CLASS A COM	46064T102	5,850	600,000	SH		OTR		600,000	0	0
INTERPRIVATE IV INFRATECH PR	*W EXP 03/05/202	46064T110	148	120,000	SH		OTR		120,000	0	0
IOVANCE BIOTRAPEUTICS INC	COM	462260100	136,605	5,250,000	SH		OTR		5,250,000	0	0
IQIYI INC	NOTE 3.750%12/0	46267XAB4	43,872	44,689,000	PRN		OTR		44,689,000	0	0
IQIYI INC	NOTE 2.000% 4/0	46267XAD0	114,113	121,762,000	PRN		OTR		121,762,000	0	0
IQIYI INC	NOTE 4.000%12/1	46267XAE8	20,143	20,000,000	PRN		OTR		20,000,000	0	0
IQVIA HLDGS INC	COM	46266C105	694,692	2,866,836	SH		OTR		2,866,836	0	0
JAWS MUSTANG ACQUISITION COR	SHS CL A	G50737108	7,808	800,000	SH		OTR		800,000	0	0
JAWS MUSTANG ACQUISITION COR	*W EXP 01/30/202	G50737124	252	200,000	SH		OTR		200,000	0	0
JAZZ INVESTMENTS I LTD	NOTE 2.000% 6/1	472145AF8	60,075	45,000,000	SH		OTR		45,000,000	0	0
KARUNA THERAPEUTICS INC	COM	48576A100	71,814	630,000	SH		OTR		630,000	0	0
KARYOPHARM THERAPEUTICS INC	NOTE 3.000%10/1	48576UAA4	10,456	10,000,000	PRN		OTR		10,000,000	0	0
KE HLDGS INC	SPONSORED ADS	482497104	13,017	273,000	SH		OTR		273,000	0	0
KHOSLA VENTURES ACQUISITION	CL A	482504107	6,923	700,000	SH		OTR		700,000	0	0
KHOSLA VENTURES ACQUSTN CO I	COM CL A	482505104	22,298	2,250,000	SH		OTR		2,250,000	0	0
KHOSLA VENTURES ACQUT CO III	COM CL A	482506102	27,809	2,809,000	SH		OTR		2,809,000	0	0
KKR ACQUISITION HOLDING I CO	COM CLASS A	48253T109	14,730	1,500,000	SH		OTR		1,500,000	0	0
KKR ACQUISITION HOLDING I CO	*W EXP 99/99/999	48253T117	443	375,000	SH		OTR		375,000	0	0
KRYSTAL BIOTECH INC	COM	501147102	5,100	75,000	SH		OTR		75,000	0	0
KURA ONCOLOGY INC	COM	50127T109	4,170	200,000	SH		OTR		200,000	0	0
LANDCADIA HOLDINGS IV INC	CLASS A COM	51477A104	4,885	500,000	SH		OTR		500,000	0	0
LANDCADIA HOLDINGS IV INC	*W EXP 03/29/202	51477A112	135	125,000	SH		OTR		125,000	0	0
LAZARD GROWTH ACQUISITION CO	SHS	G54035103	2,934	300,000	SH		OTR		300,000	0	0
LAZARD GROWTH ACQUISITION CO	*W EXP 02/10/202	G54035111	69	60,000	SH		OTR		60,000	0	0
LDH GROWTH CORP I	CLASS A ORD SHS	G54094100	1,461	150,000	SH		OTR		150,000	0	0
LDH GROWTH CORP I	*W EXP 03/17/202	G54094126	49	30,000	SH		OTR		30,000	0	0
LEVERE HOLDINGS CORP	CLASS A ORD SHS	G5462L106	7,824	800,000	SH		OTR		800,000	0	0
LEVERE HOLDINGS CORP	*W EXP 03/09/202	G5462L122	267	266,667	SH		OTR		266,667	0	0
LIVE OAK MOBILITY ACQUISI CO	COM CL A	538126103	2,450	250,000	SH		OTR		250,000	0	0
LIVE OAK MOBILITY ACQUISI CO	*W EXP 03/04/202	538126111	76	50,000	SH		OTR		50,000	0	0
LONGBOARD PHARMACEUTICALS IN	COM	54300N103	7,392	810,500	SH		OTR		810,500	0	0
LONGVIEW ACQUISITION CORP II	COM CL A	54319Q105	2,986	304,698	SH		OTR		304,698	0	0
LONGVIEW ACQUISITION CORP II	*W EXP 99/99/999	54319Q113	83	60,940	SH		OTR		60,940	0	0
LUFAX HOLDING LTD	ADS REP SHS CL A	54975P102	127,966	11,324,399	SH		OTR		11,324,399	0	0
MASTERCARD INCORPORATED	CL A	57636Q104	338,657	927,600	SH		OTR		927,600	0	0
MEDALLIA INC	COM	584021109	8,100	240,000	SH		OTR		240,000	0	0
MICROSOFT CORP	COM	594918104	464,073	1,713,078	SH		OTR		1,713,078	0	0
MIRATI THERAPEUTICS INC	COM	60468T105	145,377	900,000	SH		OTR		900,000	0	0
MOMO INC	NOTE 1.250% 7/0	60879BAB3	98,187	110,077,000	PRN		OTR		110,077,000	0	0
NATERA INC	COM	632307104	56,765	500,000	SH		OTR		500,000	0	0
NEOGENOMICS INC	COM NEW	64049M209	18,971	420,000	SH		OTR		420,000	0	0
NEW ORIENTAL ED & TECHNOLOGY	SPON ADR	647581107	1,065	130,000	SH		OTR		130,000	0	0
NEW YORK TIMES CO	CL A	650111107	288,094	6,615,258	SH		OTR		6,615,258	0	0
NIGHTDRAGON ACQUISITION CORP	CLASS A COM	65413D105	3,904	400,000	SH		OTR		400,000	0	0
NIGHTDRAGON ACQUISITION CORP	*W EXP 02/26/202	65413D113	110	80,000	SH		OTR		80,000	0	0
NORTHERN GENESIS ACQUISITION	COMMON STOCK	66516U101	2,766	278,026	SH		OTR		278,026	0	0
NORTHERN GENESIS ACQUISITION	*W EXP 01/15/202	66516U119	154	92,675	SH		OTR		92,675	0	0
NORTHERN STAR INVEST CORP II	COM CL A	66574L100	978	100,000	SH		OTR		100,000	0	0
NORTHERN STAR INVEST CORP II	*W EXP 02/25/202	66574L118	21	16,667	SH		OTR		16,667	0	0
NORTHERN STAR INVEST CORP IV	COM CL A	66575B101	985	100,000	SH		OTR		100,000	0	0
NORTHERN STAR INVEST CORP IV	*W EXP 02/25/202	66575B119	24	16,666	SH		OTR		16,666	0	0
NOVAVAX INC	COM NEW	670002401	8,492	40,000	SH		OTR		40,000	0	0
NOVUS CAPITAL CORPORATION II	COM CL A	67012W104	6,825	700,000	SH		OTR		700,000	0	0
NOVUS CAPITAL CORPORATION II	*W EXP 02/02/202	67012W112	275	233,333	SH		OTR		233,333	0	0
NUVATION BIO INC	COM CL A	67080N101	23,262	2,498,600	SH		OTR		2,498,600	0	0
ORCHARD THERAPEUTICS PLC	ADS	68570P101	14,116	3,215,434	SH		OTR		3,215,434	0	0
PACIFIC BIOSCIENCES CALIF IN	COM	69404D108	8,743	250,000	SH		OTR		250,000	0	0
PANACEA ACQUISITION CORP II	CL A SHS	G6882C106	7,500	750,000	SH		OTR		750,000	0	0
PATHFINDER ACQUISITION CORP	CL A	G04119106	7,354	750,000	SH		OTR		750,000	0	0
PATHFINDER ACQUISITION CORP	*W EXP 02/19/202	G04119122	170	150,000	SH		OTR		150,000	0	0
PG&E CORP	COM	69331C108	74,160	7,292,042	SH		OTR		7,292,042	0	0
PHARVARIS N V	COM	N69605108	1,290	71,020	SH		OTR		71,020	0	0
PLAYA HOTELS & RESORTS NV	SHS	N70544106	62,059	8,352,553	SH		OTR		8,352,553	0	0
PLIANT THERAPEUTICS INC	COM	729139105	14,269	490,000	SH		OTR		490,000	0	0
POST HOLDINGS PARTNERING COR	UNIT 99/99/9999	737465203	8,312	800,000	SH		OTR		800,000	0	0
PRIVETERRA ACQUISITION CORP	CL A	74275N102	1,445	150,000	SH		OTR		150,000	0	0
PRIVETERRA ACQUISITION CORP	*W EXP 02/28/202	74275N110	50	49,995	SH		OTR		49,995	0	0
PROTAGONIST THERAPEUTICS INC	COM	74366E102	104,556	2,329,680	SH		OTR		2,329,680	0	0
QIAGEN NV	SHS NEW	N72482123	108,341	2,239,373	SH		OTR		2,239,373	0	0
QUANTERIX CORP	COM	74766Q101	31,970	545,000	SH		OTR		545,000	0	0
QUANTUM SI INC	COM CL A	74765K105	21,455	1,750,000	SH		OTR		1,750,000	0	0
RADIUS HEALTH INC	COM NEW	750469207	38,439	2,107,400	SH		OTR		2,107,400	0	0
RADIUS HEALTH INC	NOTE 3.000% 9/0	750469AA6	6,267	6,783,000	PRN		OTR		6,783,000	0	0
RAYTHEON TECHNOLOGIES CORP	COM	75513E101	405,221	4,749,986	SH		OTR		4,749,986	0	0
READY CAPITAL CORP	COM	75574U101	19,841	1,250,226	SH		OTR		1,250,226	0	0
REINVENT TECHNOLOGY PARTNERS	CLASS A ORD SHS	G7484L106	7,410	750,000	SH		OTR		750,000	0	0
REINVENT TECHNOLOGY PARTNERS	*W EXP 03/12/202	G7484L122	169	93,750	SH		OTR		93,750	0	0
RESEARCH ALLIANCE CORP II	COM CL A	760873109	7,500	750,000	SH		OTR		750,000	0	0
REVOLUTION HEALTHCAR AQ CORP	CLASS A COM	76155Y108	19,640	2,000,000	SH		OTR		2,000,000	0	0
REVOLUTION HEALTHCAR AQ CORP	*W EXP 12/31/202	76155Y116	560	400,000	SH		OTR		400,000	0	0
REVOLUTION MEDICINES INC	COM	76155X100	79,350	2,500,000	SH		OTR		2,500,000	0	0
ROCKET INTERNET GRWT OPRT CO	SHS CL A	G7613T103	4,915	500,000	SH		OTR		500,000	0	0
ROCKET INTERNET GRWT OPRT CO	*W EXP 99/99/999	G7613T129	165	125,000	SH		OTR		125,000	0	0
ROCKET PHARMACEUTICALS INC	COM	77313F106	15,502	350,000	SH		OTR		350,000	0	0
RXR ACQUISITION CORP	CLASS A COM	74981W107	5,826	600,000	SH		OTR		600,000	0	0
RXR ACQUISITION CORP	*W EXP 03/08/202	74981W115	130	120,000	SH		OTR		120,000	0	0
SALESFORCE COM INC	COM	79466L302	360,937	1,477,615	SH		OTR		1,477,615	0	0
SAVARA INC	COM	805111101	9,269	5,452,086	SH		OTR		5,452,086	0	0
SCION TECH GROWTH II	CL A SHS	G31070108	4,365	450,000	SH		OTR		450,000	0	0
SCION TECH GROWTH II	*W EXP 01/28/202	G31070116	139	150,000	SH		OTR		150,000	0	0
SERVICENOW INC	COM	81762P102	286,865	522,000	SH		OTR		522,000	0	0
SHELTER ACQUISITION CORP I	UNIT 02/25/2026	822821203	16,484	1,650,000	SH		OTR		1,650,000	0	0
SHERWIN WILLIAMS CO	COM	824348106	284,756	1,045,168	SH		OTR		1,045,168	0	0
SLACK TECHNOLOGIES INC	COM CL A	83088V102	462,372	10,437,300	SH		OTR		10,437,300	0	0
SLAM CORP	CL A SHS	G8210L105	687	70,508	SH		OTR		70,508	0	0
SLAM CORP	*W EXP 02/23/202	G8210L121	19	17,627	SH		OTR		17,627	0	0
SOARING EAGLE ACQUISITION CO	CL A SHS	G8354H126	4,980	500,000	SH		OTR		500,000	0	0
SOARING EAGLE ACQUISITION CO	*W EXP 02/23/202	G8354H118	330	100,000	SH		OTR		100,000	0	0
SOCIAL LEVERAGE ACQUISN CORP	COM CL A	83363K102	7,289	750,000	SH		OTR		750,000	0	0
SOCIAL LEVERAGE ACQUISN CORP	*W EXP 02/17/202	83363K110	204	187,500	SH		OTR		187,500	0	0
SPARTAN ACQUISITION CORP III	COM CL A	84677R106	587	60,053	SH		OTR		60,053	0	0
SPARTAN ACQUISITION CORP III	*W EXP 02/04/202	84677R114	18	15,013	SH		OTR		15,013	0	0
SPDR S&P 500 ETF TR	TR UNIT	78462F103	1,502,491	3,510,000	SH	Call	OTR		3,510,000	0	0
SPDR S&P 500 ETF TR	TR UNIT	78462F103	2,245,603	5,246,000	SH	Put	OTR		5,246,000	0	0
SUPERNOVA PARTN ACQ CO III L	SHS CL A	G8T90F102	6,811	700,000	SH		OTR		700,000	0	0
SUPERNOVA PARTN ACQ CO III L	*W EXP 99/99/999	G8T90F128	168	140,000	SH		OTR		140,000	0	0
SUPERNOVA PARTNERS ACQUISTN	SHS CL A	G8T86C105	1,942	200,000	SH		OTR		200,000	0	0
SUPERNOVA PARTNERS ACQUISTN	*W EXP 99/99/999	G8T86C121	60	50,000	SH		OTR		50,000	0	0
SURFACE ONCOLOGY INC	COM	86877M209	7,460	1,000,000	SH		OTR		1,000,000	0	0
SVF INVESTMENT CORP	CL A SHS	G8601L102	2,470	250,000	SH		OTR		250,000	0	0
SVF INVESTMENT CORP	*W EXP 12/20/202	G8601L128	77	50,000	SH		OTR		50,000	0	0
TAILWIND TWO ACQUISITION COR	SHS CL A	G86613109	9,660	1,000,000	SH		OTR		1,000,000	0	0
TAILWIND TWO ACQUISITION COR	*W EXP 03/09/202	G86613125	333	333,333	SH		OTR		333,333	0	0
TALEND S A	ADS	874224207	24,928	380,000	SH		OTR		380,000	0	0
TCV ACQUISITION CORP	CL A SHS	G8704C124	4,955	500,000	SH		OTR		500,000	0	0
TG THERAPEUTICS INC	COM	88322Q108	19,395	500,000	SH		OTR		500,000	0	0
THE MUSIC ACQUISITION CORP	COM CLASS A	62752R100	1,209	125,000	SH		OTR		125,000	0	0
THE MUSIC ACQUISITION CORP	*W EXP 02/05/202	62752R118	53	62,500	SH		OTR		62,500	0	0
THERAPEUTICS ACQUISITION COR	COM CL A	88339T103	24,672	2,400,000	SH		OTR		2,400,000	0	0
THERAVANCE BIOPHARMA INC	COM	G8807B106	1,394	96,000	SH		OTR		96,000	0	0
THERAVANCE BIOPHARMA INC	NOTE 3.250%11/0	88339KAA0	54,114	56,695,000	PRN		OTR		56,695,000	0	0
THERMO FISHER SCIENTIFIC INC	COM	883556102	678,047	1,344,078	SH		OTR		1,344,078	0	0
THUNDER BRIDGE CAP PRTNRS II	COM CL A	88605T100	7,290	750,000	SH		OTR		750,000	0	0
THUNDER BRIDGE CAP PRTNRS II	*W EXP 02/15/202	88605T118	195	150,000	SH		OTR		150,000	0	0
TIGA ACQUISITION CORP	SHS CL A	G88672103	10,832	1,080,000	SH		OTR		1,080,000	0	0
TIGA ACQUISITION CORP	*W EXP 11/06/202	G88672111	605	540,000	SH		OTR		540,000	0	0
TIO TECH A	CLASS A ORD SHS	G8T10C106	4,840	500,000	SH		OTR		500,000	0	0
TIO TECH A	*W EXP 04/12/202	G8T10C114	168	166,666	SH		OTR		166,666	0	0
T-MOBILE US INC	COM	872590104	499,444	3,448,481	SH		OTR		3,448,481	0	0
TPG PACE BENEFICIAL II CORP	COMMON STOCK	G89826104	7,560	750,000	SH		OTR		750,000	0	0
TPG PACE SOLUTIONS CORP	SHS CL A	G8656V104	3,486	350,000	SH		OTR		350,000	0	0
TRANSUNION	COM	89400J107	305,577	2,782,782	SH		OTR		2,782,782	0	0
TURNING POINT THERAPEUTICS I	COM	90041T108	36,279	465,000	SH		OTR		465,000	0	0
UNIQURE NV	SHS	N90064101	9,240	300,000	SH		OTR		300,000	0	0
VECTOR ACQUISITION CORP II	CL A SHS	G9460A104	7,448	750,000	SH		OTR		750,000	0	0
VIRGIN GROUP ACQUISIT CORP I	SHS CL A	G9460K102	9,790	1,000,000	SH		OTR		1,000,000	0	0
VIRGIN GROUP ACQUISIT CORP I	*W EXP 03/13/202	G9460K128	256	200,000	SH		OTR		200,000	0	0
VISA INC	COM CL A	92826C839	292,136	1,249,404	SH		OTR		1,249,404	0	0
VPC IMPACT ACQU HOLDI III IN	COM CL A	91835J108	5,934	600,000	SH		OTR		600,000	0	0
VPC IMPACT ACQU HOLDI III IN	*W EXP 09/03/202	91835J116	158	100,000	SH		OTR		100,000	0	0
VPC IMPACT ACQUISITION HLDG	CLASS A ORD	G9460L126	4,157	425,000	SH		OTR		425,000	0	0
VPC IMPACT ACQUISITION HLDG	*W EXP 03/05/202	G9460L118	122	106,250	SH		OTR		106,250	0	0
WABTEC	COM	929740108	434,120	5,274,851	SH		OTR		5,274,851	0	0
WARBURG PINCUS CAPTAL CORP I	SHS CL A	G9460M108	7,410	750,000	SH		OTR		750,000	0	0
WARBURG PINCUS CAPTAL CORP I	SHS CL A	G9461D107	7,403	750,000	SH		OTR		750,000	0	0
WARBURG PINCUS CAPTAL CORP I	*W EXP 99/99/999	G9461D115	212	150,000	SH		OTR		150,000	0	0
WARBURG PINCUS CAPTAL CORP I	*W EXP 99/99/999	G9460M124	195	150,000	SH		OTR		150,000	0	0
WILLIS TOWERS WATSON PLC LTD	SHS	G96629103	799,241	3,474,660	SH		OTR	1	3,474,660	0	0
ZEALAND PHARMA A/S	SPONSORED ADR	98920Y304	15,071	510,000	SH		OTR		510,000	0	0
ZOGENIX INC	COM NEW	98978L204	38,880	2,250,000	SH		OTR		2,250,000	0	0